Nevro Corp
(NVRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 12-2012 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | N/A | 5,610 |
| Marketable Securities | N/A | 24,990 |
| Receivables | N/A | 5,850 |
| Inventories | N/A | 9,580 |
| Other current assets | 0 | 2,790 |
| TOTAL | $N/A | $48,820 |
| Non-Current Assets | ||
| PPE Net | N/A | 390 |
| Other Non-Current Assets | 0 | 180 |
| TOTAL | $N/A | $570 |
| Total Assets | $N/A | $49,110 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 1,950 |
| Accrued Expenses | N/A | 2,810 |
| Other current liabilities | N/A | 480 |
| TOTAL | $N/A | $5,240 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 0 | 240 |
| TOTAL | $N/A | $240 |
| Total Liabilities | $N/A | $5,490 |
| Shareholders' Equity | ||
| Common Shares | N/A | 1 |
| Retained earnings | N/A | -64,980 |
| Other shareholders' equity | 0 | 105,409 |
| TOTAL | $N/A | $43,610 |
| Total Liabilities And Equity | $0 | $49,100 |